The Health Resources and Services Administration threatened to fine drug makers that continue to restrict discounts to hospitals and clinics that dispense 340B drugs through multiple contract pharmacies, and HRSA said drug makers must refund hospitals. However, it’s not clear that the letters that HRSA sent on Monday (May 17) will change drug maker behavior, and the entire thing could land in court with a lot of money on the line, hospital lawyers said. HRSA Acting Administrator Diana Espinosa told...